KR940703666A - 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction) - Google Patents
발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)Info
- Publication number
- KR940703666A KR940703666A KR1019940702181A KR19940702181A KR940703666A KR 940703666 A KR940703666 A KR 940703666A KR 1019940702181 A KR1019940702181 A KR 1019940702181A KR 19940702181 A KR19940702181 A KR 19940702181A KR 940703666 A KR940703666 A KR 940703666A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- treatment
- erectile dysfunction
- potent drug
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title claims 2
- 208000010228 Erectile Dysfunction Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 201000001881 impotence Diseases 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 claims abstract 2
- 230000001939 inductive effect Effects 0.000 claims abstract 2
- 238000002347 injection Methods 0.000 claims abstract 2
- 239000007924 injection Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 210000005226 corpus cavernosum Anatomy 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- HKZNADVVGXKQDL-UHFFFAOYSA-N 1-cyano-2-(2-methylbutan-2-yl)-3-(3-pyridinyl)guanidine Chemical compound CCC(C)(C)N=C(NC#N)NC1=CC=CN=C1 HKZNADVVGXKQDL-UHFFFAOYSA-N 0.000 abstract 1
- 208000010201 Exanthema Diseases 0.000 abstract 1
- 201000005884 exanthem Diseases 0.000 abstract 1
- 210000003899 penis Anatomy 0.000 abstract 1
- -1 pyridylguanidine compound Chemical class 0.000 abstract 1
- 206010037844 rash Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
음경에 소량의 피리딜구아니딘 화합물, 바람직하게는 N-시아노-N'-(1,1-디메틸 프로필)-N"-(3-피리디닐)구아니딘을 투여하므로써 발기를 유도 또는 증진시키거나 또는 발진 부전증을 치료하기 위한 방법, DMARUD 해면체로내로의 주사 또는 경피적 적용에 의해 투여할 수 있다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 포유동물에서 발기를 유도하거나 또는 증진시키는데 유용한 약물을 제조하기 위한, 하기 일반식(Ⅰ)의 화합물 또는 그의 약학적으로 허용가능한 염의 용도.상기식에서, R1및 R2는 독립적으로 수소, 또는 C1-8알킬, C2-8알켄, C3-8사이클로알킬 및 그의 이성체 형태이다.
- 제1항에 있어서, 일반식(Ⅰ)의 화합물을 음경 해면체내에 주사하는 용도.
- 제1항에 있어서, 일반식(Ⅰ)의 화합물이 N-시아노-N'-(1,1-디메틸프로필)-N"-(3-피리디닐)구아니던 또는 그의 약학적으로 허용가능한 염인 용도.
- 제2항에 있어서, 인간에서 0.5㎍ 내지 1000㎍의 양으로 주사하는 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81670091A | 1991-12-23 | 1991-12-23 | |
| US07816700 | 1991-12-23 | ||
| PCT/US1992/010254 WO1993012788A1 (en) | 1991-12-23 | 1992-12-02 | Pyridylguanidine compounds for treatment of erectile dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR940703666A true KR940703666A (ko) | 1994-12-12 |
Family
ID=25221384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940702181A Abandoned KR940703666A (ko) | 1991-12-23 | 1992-12-02 | 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction) |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5488059A (ko) |
| EP (1) | EP0618798B1 (ko) |
| JP (1) | JPH07506333A (ko) |
| KR (1) | KR940703666A (ko) |
| AT (1) | ATE149834T1 (ko) |
| AU (1) | AU661747B2 (ko) |
| CA (1) | CA2123312A1 (ko) |
| DE (1) | DE69218246T2 (ko) |
| DK (1) | DK0618798T3 (ko) |
| ES (1) | ES2099293T3 (ko) |
| GR (1) | GR3023448T3 (ko) |
| WO (1) | WO1993012788A1 (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6007836A (en) * | 1993-05-28 | 1999-12-28 | Vericade, Inc. | Transdermal vasodilator |
| US5741511A (en) * | 1995-04-12 | 1998-04-21 | Sam Yang Co., Ltd. | Transdermal drug delivery device for treating erectile dysfunction |
| US5952006A (en) * | 1995-09-29 | 1999-09-14 | L.A.M. Pharmaceuticals, Llc | Drug preparations for treating impotency |
| US6063405A (en) * | 1995-09-29 | 2000-05-16 | L.A.M. Pharmaceuticals, Llc | Sustained release delivery system |
| US6036977A (en) * | 1995-09-29 | 2000-03-14 | L.A.M. Pharmaceutical Corp. | Drug preparations for treating sexual dysfunction |
| US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
| US6417207B1 (en) | 1999-05-12 | 2002-07-09 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| US6436944B1 (en) * | 1999-09-30 | 2002-08-20 | Pfizer Inc. | Combination effective for the treatment of impotence |
| KR20010076961A (ko) * | 2000-01-29 | 2001-08-17 | 김제종 | 성기능장애 예방 및 치료용 약제 |
| EP1917244A2 (de) | 2005-08-24 | 2008-05-07 | Abbott GmbH & Co. KG | Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1489879A (en) * | 1974-12-20 | 1977-10-26 | Leo Pharm Prod Ltd | N'-cyano-n'-3-pyridylguanidines |
| US4127118B1 (en) * | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
| US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
| US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
-
1992
- 1992-12-02 AU AU31497/93A patent/AU661747B2/en not_active Ceased
- 1992-12-02 ES ES92925443T patent/ES2099293T3/es not_active Expired - Lifetime
- 1992-12-02 CA CA002123312A patent/CA2123312A1/en not_active Abandoned
- 1992-12-02 WO PCT/US1992/010254 patent/WO1993012788A1/en not_active Ceased
- 1992-12-02 EP EP92925443A patent/EP0618798B1/en not_active Expired - Lifetime
- 1992-12-02 DE DE69218246T patent/DE69218246T2/de not_active Expired - Fee Related
- 1992-12-02 KR KR1019940702181A patent/KR940703666A/ko not_active Abandoned
- 1992-12-02 AT AT92925443T patent/ATE149834T1/de not_active IP Right Cessation
- 1992-12-02 JP JP5511657A patent/JPH07506333A/ja active Pending
- 1992-12-02 DK DK92925443.1T patent/DK0618798T3/da active
-
1994
- 1994-05-27 US US08/250,193 patent/US5488059A/en not_active Expired - Fee Related
-
1997
- 1997-05-16 GR GR970401097T patent/GR3023448T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3023448T3 (en) | 1997-08-29 |
| DK0618798T3 (da) | 1997-09-22 |
| WO1993012788A1 (en) | 1993-07-08 |
| CA2123312A1 (en) | 1993-07-08 |
| JPH07506333A (ja) | 1995-07-13 |
| EP0618798B1 (en) | 1997-03-12 |
| ES2099293T3 (es) | 1997-05-16 |
| DE69218246D1 (de) | 1997-04-17 |
| ATE149834T1 (de) | 1997-03-15 |
| AU661747B2 (en) | 1995-08-03 |
| EP0618798A1 (en) | 1994-10-12 |
| AU3149793A (en) | 1993-07-28 |
| DE69218246T2 (de) | 1997-07-17 |
| US5488059A (en) | 1996-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69130529D1 (de) | Behandlung von erektionversagen | |
| KR880012218A (ko) | 캘폰 유도체를 사용한 다발성 경화증의 치료방법 | |
| KR900701282A (ko) | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 | |
| KR910019618A (ko) | 발기부전증 치료용 제약 조성물 | |
| KR920012113A (ko) | 펩타이드 유도체의 사용방법 | |
| NZ255278A (en) | Treatment of sexual dysfunction using an h2 agonist (heterocyclic substituted n-methyl thioethyl guanidine or aminopropylisothiourea derivatives) | |
| KR940703666A (ko) | 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction) | |
| KR950007848A (ko) | (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법 | |
| KR900007424A (ko) | 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물 | |
| RU2003118131A (ru) | Способ лечения ран | |
| KR950016760A (ko) | 치질 치료제 | |
| KR900005974A (ko) | 남성의 성기능 장애 치료제 | |
| IT9009007A1 (it) | 2, 4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili | |
| KR920019350A (ko) | 자기면역질환요법을 위한 약제조성물 | |
| DK0517876T3 (da) | Terapeutiske benzazepinforbindelser | |
| JPS6452719A (en) | Heterocyclic sulfide | |
| KR970701191A (ko) | 복소환 화합물 | |
| KR910004609A (ko) | 아미노케톤 유도체 및 그의 용도 | |
| KR890012942A (ko) | 5-치환된 오르니틴 유도체 | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| KR950010896A (ko) | 근시의 예방 및 치료용 조성물 | |
| KR890003372A (ko) | 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약 | |
| KR890007737A (ko) | 진토작용을 하는 약제 | |
| KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
| KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19940622 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970826 Comment text: Request for Examination of Application |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19990727 |
|
| NORF | Unpaid initial registration fee | ||
| PC1904 | Unpaid initial registration fee |